Skip to content
← Full study record

NCT03582475 · MORE INFO

Limitations, agreements, and source contact

Pembrolizumab With Combination Chemotherapy in Treating Participants With Locally Advanced or Metastatic Small Cell/Neuroendocrine Cancers of Urothelium or Prostate · Source last updated 2025-11-12

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
false
restrictive Agreement
false
point Of Contact
email
SaraRodriguez@mednet.ucla.edu
organization
UCLA / Department of Radiology
phone
310-794-2877
title
Sara Rodriguez
Complete source fields
certain Agreement
pi Sponsor Employee
false
restrictive Agreement
false
point Of Contact
email
SaraRodriguez@mednet.ucla.edu
organization
UCLA / Department of Radiology
phone
310-794-2877
title
Sara Rodriguez

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice